Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Augmented Reality eCommerce Firm Selects Fortune 500 Tech Executive to Head 3D/AR Ad Network

NexTech AR Solutions reported that it has hired Guillaume Pascual as director of 3D/AR Ads. NexTech AR Solutions Corp. (NTAR:CSE; NEXCF:OTCQB) , stated in a release that "it is pleased to announce that Guillaume Pascual has been hired to serve as Director ...

Pinduoduo Stock Gains 15% After Company Reports Triple-Digit Increase in Quarterly Revenue

One year following its IPO, Chinese mobile and internet e-commerce platform company Pinduoduo Inc. reported 169% revenue growth and an 88% growth in monthly active users. Shanghai-based virtual bazaar mobile e-commerce platform operator Pinduoduo Inc. (PDD:NASDAQ) t...

The Surging AR Company Leading the Industry

3D AR ads are coming to the market faster than you might think. Omri Wallach of Stockhouse Media was recently joined live on the line by Evan Gappelberg, CEO of NexTech AR Solutions ( CSE:NTAR , OTC:NEXCF , Forum ), fresh off the Company's recent re...

Winners and losers from Facebook's botched IPO

In less than a week's time, the Facebook IPO has gone from the most-hyped technology event since Google went public into "blame-storming" mode. Details concerning the stock's sudden drop, the market's inability to process orders, and the (mis)behavior of insiders are start...

Millennials and Baby Boomers – What their Stock Portfolio Reveals

Although millennials are now of age, their influence on the stock market is still in its infancy. The question is, can they produce better results than the older generation, known as baby boomers, who are soon to retire? To get the answer to this question, two stock portf...

Q2 Earnings Soar for AI-Assisted Advertising Technology Firm

This small-cap firm saw rapid growth and reported a record second quarter. Adcore Inc. (ADCO:TSX.V) , the developer of machine-learning powered advertising technologies, reported record second quarter financials, including an increase in revenue growth of 53% year o...

Analyst Report Values Gold Junior 239% Over Current Price

Vancouver-based junior exploration Company Etruscus Resources Corp. ( CSE: ETR , OTC: ETRUF , Forum ) was recently covered by TSXV Research , looking at its Rock and Roll and Sugar properties located in the prolific Golden Triangle region of British Columbia, which boasts...

The New Age of Advertising

With my involvement at Heelo, I have learned a lot about the new advertising world. There has been and still is a huge transformation taking place to digital advertising. You have experience with this from Google and Facebook that along with YouTube see the most web traf...

NexTech AR Solutions Update After Major Ramp-Up

Technical analyst Clive Maund provides an update on the prospects for this technology firm. While clivemaund.com is primarily a resource stocks website, we recognize that investing is an opportunity cost game, and for this reason we have no problem buying a tech stock...

BeiGene Shares Up 35% on Amgen's $2.7 Billion Investment and China Partnership

Shares of BeiGene Ltd. traded 35% higher today to a new a 52-week intraday high after announcing a commercialization agreement for of XGEVA (denosumab), KYPROLIS (carfilzomib), and BLINCYTO (blinatumomab) with Amgen Inc. in China. As part of the partnership, Amgen will invest ...
1 2 3 4 5 6 7 8 9 10 ...